Dr. Randy Brown, MD, Global Senior Director of Respiratory Medicine for Teva Pharmaceuticals, discusses symptoms and tips for managing asthma during allergy season. He talks about the best ways to communicate asthma symptoms during a telehealth appointment, and how technology such as Teva’s Digihaler® family of inhalers can help inform treatment decisions and improve communication with a healthcare professional.
Dr. Randall Brown is global senior director of respiratory medicine for Teva Pharmaceuticals. Retiring as director of asthma & COPD programs at the University of Michigan’s Center for Managing Chronic Disease, for 15 years he has maintained professorship appointments at the University’s School of Public Health. Dr. Brown received BA and MD degrees from the University of Michigan, and received his Master of Public Health degree from Harvard University. He conducted a Pediatrics residency at Boston University; and, Dr. Brown graduated from clinical fellowship in Pediatric Pulmonology at Harvard Medical School working at both The Children’s Hospital and Brigham and Women’s Hospital in Boston. He has received board certification in General Pediatrics and Pediatric Pulmonology. Dr. Brown also completed a COPD/Asthma respiratory epidemiology research fellowship at Harvard’s Channing Laboratory—and has led respiratory and allergy management behavior change investigation of women, children, obesity-burdened and other at-risk populations across the US. Since 2014, Dr. Brown has served as principal investigator for five large national chronic disease research grants that explore the translation of effective educational models in both community and clinical practice and how they affect individuals and families of all ages who shoulder disproportionate disease concern. Taking lessons from his adult asthma work, Dr. Brown and his BWWP team explored a large community-based, health educator-led, self-regulation model designed to impact transgenerational obesity in the most vulnerable US sub-population. As part of a national collaborative, Dr. Brown also led primary care practice feasibility investigation of a new COPD screening tool (CAPTURE) aimed at improving recognition and management of a leading cause of US death. Too, Dr. Brown led the 5-borough asthma educational program planning for the largest health care network in New York City; developing an evidence-based interconnected asthma e-learning model for all primary care clinicians in 2018 and 2019. Having previously served as research director for the largest clinical pediatric pulmonology practice in the US, Dr. Brown is extensively published in allergy, ENT, pulmonology, family medicine, pediatric and public health journals and has received numerous clinical and teaching honors–including the 2007 AAOA Fellowship Award and, in 2019, the National Medical Association’s Ella Mae Simmons Award for asthma education and advocacy. Notably, his 2012 first-authored work in JACI represents the largest prospective study of asthma therapeutics among African American adults ever conducted. Also, Dr. Brown is a member of the first international Respiratory Effectiveness Group–a panel devoted to incorporating rigorous understanding of adherence and other real-world measures into the science of evidence-based decision models for asthma and COPD. The award-winning asthma education program for medical professionals, PACE, of which Dr. Brown is director and co-author, is accepted internationally (US, UK and Australia) by numerous national asthma projects as the model for effective clinician respiratory education — PACE remains accessible via the National Institutes of Health asthma website. Lastly, as one of only a few US pulmonologists recognized as a nationally certified asthma educator (AE-C), Dr. Brown has served on the board of directors of the National Asthma Educator Certification Board (2013 – 2017) and the Allergy & Asthma Network (2016 – 2019).